This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Park, S. Articles by James, C. D. Search for Related Content PubMed PubMed Citation Articles by Park, S. Articles by James, C. D.

Lanthionine Synthetase Components C-like 2 Increases Cellular Sensitivity to Adriamycin by Decreasing the Expression of P-Glycoprotein through a Transcription-mediated Mechanism¹

Department of Laboratory Medicine and Pathology and Tumor Biology Program, Mayo Clinic and Foundation, Rochester, Minnesota 55905

Although the coincidental amplification and accompanying overexpressionof bystander genes that neighbor oncogene targets occur frequently during the development of human tumors, little has been done to investigate the functional or biological consequences of amplified bystander gene overexpression. LANCL2 (LANC-like 2) is a bystander gene that is coamplified and overexpressed with epidermal growth factor receptor in 20% of all glioblastomas. This gene has also been designated as Testis Adriamycin Sensitivity Protein because it is most highly expressed in testis and its expression has been noted to increase cellular sensitivity to Adriamycin. Because of the latter association, we have examined potential relationships between LANCL2 and the expression of multidrug-resistance (MDR)1, as well as its cognate protein, P-glycoprotein (P-gp), because elevated expression of P-gp is known to increase cell resistance to many cytotoxic drugs, including Adriamycin. Using the Dx5 derivative of MES-SA cells in which P-gp is overexpressed, we show that the level of endogenous P-gp decreases with increased expression of exogenous LanCl-2 and that cells with reduced P-gp show increased sensitivity to Adriamycin. Results from reverse transcription-PCR and MDR1 promoter activity analyses suggest that LanCl-2 transcriptionally suppresses MDR1, and this interpretation of LanCl-2 function is consistent with results from immunofluorescence analysis, which shows that LanCl-2 resides in the nucleus, as well as at the plasma membrane. With respect to this study, our data indicate that LanCl-2 increases cellular sensitivity to Adriamycin by decreasing the expression of P-gp, but more generally, these results indicate that the identification of bystander gene amplification in human tumors can have clinical implications.

This article has been cited by other articles:

				Z. Lu, L. Zhou, P. Killela, A. B. Rasheed, C. Di, W. E. Poe, R. E. McLendon, D. D. Bigner, C. Nicchitta, and H. Yan Glioblastoma Proto-oncogene SEC61{gamma} Is Required for Tumor Cell Survival and Response to Endoplasmic Reticulum Stress Cancer Res., December 1, 2009; 69(23): 9105 - 9111. [Abstract] [Full Text] [PDF]

				L. Sturla, C. Fresia, L. Guida, S. Bruzzone, S. Scarfi, C. Usai, F. Fruscione, M. Magnone, E. Millo, G. Basile, et al. LANCL2 Is Necessary for Abscisic Acid Binding and Signaling in Human Granulocytes and in Rat Insulinoma Cells J. Biol. Chem., October 9, 2009; 284(41): 28045 - 28057. [Abstract] [Full Text] [PDF]